C. M. Rudin - Mem Sloan Kettering Canc Ctr

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 15 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

228P SMARCA4 inactivation drives aggressiveness in STK11/KEAP1 co-mutant lung adenocarcinomas through the induction of TGFβ signaling

Á. Quintanal-Villalonga, E. Costa, C. Wohlheiter, S. Tischfield, E. Redin, H. Sridhar, A. Funnel, J.T. Poirier, Y. Hao, D. Kinyua, B. de Mello, J.E. Lazar,

ESMO Open (2024)

引用0浏览0引用

Safety and clinical activity of atezolizumab plus erlotinib in patients with non-small-cell lung cancer

C.M. Rudin,A. Cervantes, A. Dowlati,B. Besse, B. Ma, D.B. Costa, P. Schmid,R. Heist, V.M. Villaflor, J. Spahn,S. Li, E. Cha,

ESMO Open（2023）

引用3浏览0WOS引用

RESILIENT part 2: A randomized, open-label phase III study of liposomal irinotecan versus topotecan in adults with relapsed small cell lung cancer (SCLC)

C. M. Rudin,A. Dowlati,Y. Chen,A. F. Navarro Mendivil,J. C-H. Yang, G. Stojanovic, P. Rich, Z. G. Andric,Y-L. Wu, H. Chen, L. Zhang, S. Yeung,

JOURNAL OF THORACIC ONCOLOGY（2023）

引用0浏览0WOS引用

MA18.10 Phase 2 Multicohort Study of CC-90011, a LSD1 Inhibitor, in Combination with Nivolumab in Patients with Advanced Lung Cancer

C.M. Rudin, A. Navarro, E. Carcereny, L.C. Villaruz, G. Lo Russo, C. Ricordel, A. Bearz, J. Li, I. Elias, A. Bhingare, E. Morris, S. Popat

Journal of Thoracic Oncologyno. 11 (2023): S169-S169

引用0浏览0引用

Phase 2 Multicohort Study of CC-90011, a LSD1 Inhibitor, in Combination with Nivolumab in Patients with Advanced Lung Cancer

C. M. Rudin, A. Navarro, E. Carcereny, L. C. Villaruz, G. Lo Russo, C. Ricordel,A. Bearz, J. Li,I. Elias, A. Bhingare,E. Morris, S. Popat

JOURNAL OF THORACIC ONCOLOGYno. 11 (2023): S169-S169

引用0浏览0引用

Exportin 1 Inhibition Constraints Lineage Plasticity and Histological Transformation through Downregulation of SOX2

A. Quintanal-Villalonga,V. Durani,A. Sabet,E. Redin,K. Kawasaki,M. Shaffer,P. Manoj,H. Sridhar,M. C. Haffner,C. L. Sawyers,C. M. Rudin

JOURNAL OF THORACIC ONCOLOGYno. 11 (2023): S87-S88

引用0浏览0引用

OA19.03 Exportin 1 Inhibition Constraints Lineage Plasticity and Histological Transformation through Downregulation of SOX2

A. Quintanal-Villalonga,V. Durani,A. Sabet,E. Redin,K. Kawasaki,M. Shaffer,P. Manoj,H. Sridhar,M.C. Haffner,C.L. Sawyers,C.M. Rudin

Journal of Thoracic Oncologyno. 11 (2023): S87-S88

引用0浏览0引用

Radiotheranostics targeting Delta-Like Ligand 3 Expressing Small-Cell Lung Cancers

S. Tendler, T. Hoang, D. Bauer, J. Korsen, L. Carter, A. Michel, R. Degregorio,N. Pillarsetty,J. T. Poirier, J. S. Lewis,C. M. Rudin

JOURNAL OF THORACIC ONCOLOGYno. 11 (2023): S704-S704

引用0浏览0引用

Phase II, multicenter, randomized, open-label study of DS-7300 in patients (pts) with pre-treated extensive-stage small cell lung cancer (ES-SCLC)

L. Paz-Ares,M. L. Johnson, N. Girard, C. L. Hann,M-J. Ahn, M. Nishio, J. Godard, A. Laadem, N. Yoshizuka, M. Qian, B. Cheng,C. M. Rudin

Annals of Oncologyno. 7 (2022): S1255-S1256

引用1浏览0引用

APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas

P. Selenica,A. Marra, N.J. Choudhury,A. Gazzo, C.J. Falcon, J. Patel,X. Pei, Y. Zhu,C.K.Y. Ng, M. Curry,G. Heller, Y.-K. Zhang,

Annals of Oncology（2022）

引用13浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn